Original Research
Published on 20 Apr 2021
The Struggling Odyssey of Infantile Primary Hyperoxaluria
in Pediatric Nephrology
Frontiers in Pediatrics
doi 10.3389/fped.2021.615183
- 4,871 views
- 12 citations
15 articles related to "Primary Hyperoxaluria"
Articles
Brief Research Report
Published on 22 Feb 2024
Bone health in children with primary hyperoxaluria type 1 following liver and kidney transplantation
in Pediatric Nephrology
Frontiers in Pediatrics
doi 10.3389/fped.2024.1353880
- 2,723 views
- 4 citations
Original Research
Published on 17 Apr 2023
Four novel variants identified in primary hyperoxaluria and genotypic and phenotypic analysis in 21 Chinese patients
in Genetics of Common and Rare Diseases
Frontiers in Genetics
doi 10.3389/fgene.2023.1124745
- 5,038 views
- 6 citations
Review
Published on 10 Jan 2023
Lumasiran for primary hyperoxaluria type 1: What we have learned?
in Pediatric Nephrology
Frontiers in Pediatrics
doi 10.3389/fped.2022.1052625
- 10,214 views
- 24 citations
Case Report
Published on 05 Jan 2022
Case Report: Sustained Efficacy of Lumasiran at 18 Months in Primary Hyperoxaluria Type 1
in Pediatric Nephrology
Frontiers in Pediatrics
doi 10.3389/fped.2021.791616
- 3,568 views
- 9 citations
Original Research
Published on 17 Mar 2023
Long-term outcome after combined or sequential liver and kidney transplantation in children with infantile and juvenile primary hyperoxaluria type 1
in Pediatric Nephrology
Frontiers in Pediatrics
doi 10.3389/fped.2023.1157215
- 3,583 views
- 9 citations
Case Report
Published on 16 Jan 2024
Case Report: effect of lumasiran treatment in a late preterm baby with antenatal diagnosis of primary hyperoxaluria type 1
in Pediatric Nephrology
Frontiers in Pediatrics
doi 10.3389/fped.2023.1338909
- 3,200 views
- 3 citations
Case Report
Published on 13 May 2025
Primary hyperoxaluria type I diagnosed after a kidney transplant presenting with subcutaneous calcification: a case report of sodium thiosulfate treatment
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1485024
- 2,142 views
Original Research
Published on 06 Feb 2019
Two Novel AGXT Mutations Cause the Infantile Form of Primary Hyperoxaluria Type I in a Chinese Family: Research on Missed Mutation
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2019.00085
- 5,786 views
- 9 citations
Original Research
Published on 09 Apr 2021
Natural History of Clinical, Laboratory, and Echocardiographic Parameters of a Primary Hyperoxaluria Cohort on Long Term Hemodialysis
in Nephrology
Frontiers in Medicine
doi 10.3389/fmed.2021.592357
- 3,657 views
- 11 citations
Original Research
Published on 04 May 2022
Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening
in Chemical Biology
Frontiers in Chemistry
doi 10.3389/fchem.2022.844598
- 6,775 views
- 5 citations
Original Research
Published on 25 Sep 2018
The Long Pentraxin PTX3 Is an Endogenous Inhibitor of Hyperoxaluria-Related Nephrocalcinosis and Chronic Kidney Disease
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2018.02173
- 7,159 views
- 16 citations
Perspective
Published on 07 Dec 2023
Pediatric renal lithiasis in Spain: research, diagnostic and therapeutic challenges, and perspectives
in Pediatric Nephrology
Frontiers in Pediatrics
doi 10.3389/fped.2023.1294319
- 3,547 views
- 1 citation
Clinical Trial
Published on 16 Sep 2024
Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 30-month analysis of the phase 3 ILLUMINATE-B trial
in Pediatric Nephrology
Frontiers in Pediatrics
doi 10.3389/fped.2024.1392644
- 5,082 views
- 8 citations
Original Research
Published on 20 Sep 2021
Primary Hyperoxaluria Type 1 Disease Manifestations and Healthcare Utilization: A Multi-Country, Online, Chart Review Study
in Nephrology
Frontiers in Medicine
doi 10.3389/fmed.2021.703305
- 8,987 views
- 12 citations